Replies to post #424 on Ionis Pharmaceuticals Inc (IONS)

[shub]

Percival; you are assuming that all our clinical trials are successful, which is unlikely. New drug development has an inherently high failure rate, and that should be expected by a reasonable share holder.
Expect the PPS to fluctuate all over the place along the way.
That said, IONS is one of my larger holdings.